Institute Scientist, The Feinstein Institute for Medical Research
Phone: (516) 562-3466
Email: hkaku@nshs.edu
Hiroaki Kaku, PhD, is the Head of the Laboratory of Cellular Stress and an Institute Scientist at the Feinstein Institute for Medical Research. He completed his undergraduate work at the University of Tokyo, Japan and also received a PhD in Immunology from the University of Tokyo in 2004.
Dr. Kaku spent 1 year at the University of Tokyo as a postdoctoral fellow. He then continued his postdoctoral training in Dr. Rothstein’s lab, first at Boston University then at the Feinstein Institute for Medical Research, studying the molecular mechanisms of B cell activation. In 2009, Dr. Kaku was promoted to an Institute Scientist at the Feinstein Institute for Medical Research.
In 2014, Dr. Kaku’s laboratory turned its focus onto cellular stress. He is now interested in how our cells fight against various cellular stresses and why the failure of this protection causes various diseases such as cataracts, neurodegenerative diseases, and myopathies.
The cells and tissues in our bodies are continuously exposed to various stresses including heat, cold, UV, oxidative and toxic stresses, and infection. Heat shock proteins (HSPs) play a crucial role in protecting cells from these stresses therefore maintaining cellular viability and tissue homeostasis. HSPs are found in all living organisms from bacteria and plants to humans. HSPs are divided into 6 major groups: small HSPs (sHSPs), HSP40, HSP60, HSP70, HSP90, and large HSPs.
Dr. Kaku’s group currently focuses on the functions of sHSPs since they are involved in the mechanism of aging-related diseases including cataracts, neurodegenerative diseases, and myopathies. Thus, his laboratory team aims to elucidate how sHSPs render resistance to cellular stresses.
The University of Tokyo, Japan
Degree: BS
1997
Field of Study: Public Health
The University of Tokyo, Japan
Degree: MS
1999
Field of Study: Immunology
The University of Tokyo, Japan
Degree: PhD
2004
Field of Study: Immunology
- Kaku H. (Corresponding Author), Cheng K.F., Al-Abed Y., Rothstein T.L.. CD73 “A Novel Mechanism of B Cell-Mediated Immune Suppression through CD73 Expression and Adenosine Production.” 2014. J Immunol 193(12):5904-13 (PMID: 25392527).
- Rothstein T.L., Griffin D.O., Holodick N.E., Quach T.D., Kaku H. “Human B-1 cells take the stage.” 2013. Ann N Y Acad Sci. 2013.1285:97-114 (PMID: 23692567). Review.
The post Hiroaki Kaku, PhD appeared first on The Feinstein Institute for Medical Research.